Yana CPA - Isracann Biosciences Corp CFO

Insider

Yana CPA is Corp CFO of Isracann Biosciences
Age 41
Phone604 394 2551
Webhttps://www.isracann.com

Isracann Biosciences Management Efficiency

The company has return on total asset (ROA) of (0.3499) % which means that it has lost $0.3499 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5275) %, meaning that it generated substantial loss on money invested by shareholders. Isracann Biosciences' management efficiency ratios could be used to measure how well Isracann Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Thomas HemingwayBioQuest Corp
66
Steven LightmanGrown Rogue International
66
Pamela DailyBioQuest Corp
72
John HellerGoodness Growth Holdings
54
Eric JDGoodness Growth Holdings
44
Albert ZakesGoodness Growth Holdings
N/A
Harris RabinGoodness Growth Holdings
48
Adam AugustGrown Rogue International
45
Christian OcasioGoodness Growth Holdings
41
David NoyesBioQuest Corp
80
Jefferey DonnellBioQuest Corp
72
Michael KrallBioQuest Corp
71
Sam GibbonsGoodness Growth Holdings
N/A
Joshua RosenGoodness Growth Holdings
50
Michael SchroederGoodness Growth Holdings
56
Kyle MDGoodness Growth Holdings
48
Eric ShoemakerC21 Investments
N/A
Buddy WilsonGrown Rogue International
N/A
Obie StricklerGrown Rogue International
40
Sonny NewmanC21 Investments
N/A
Stephen MDGoodness Growth Holdings
48
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. Isracann Biosciences is traded on OTC Exchange in the United States. Isracann Biosciences [ISCNF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Isracann Biosciences Leadership Team

Elected by the shareholders, the Isracann Biosciences' board of directors comprises two types of representatives: Isracann Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Isracann. The board's role is to monitor Isracann Biosciences' management team and ensure that shareholders' interests are well served. Isracann Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Isracann Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
James Thompson, Chief Officer
Matthew Chatterton, Chief Officer
Phil Floucault, Pres CEO
Yana CPA, Corp CFO

Isracann Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Isracann Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Isracann Pink Sheet

Isracann Biosciences financial ratios help investors to determine whether Isracann Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Isracann with respect to the benefits of owning Isracann Biosciences security.